Nature Reviews Rheumatology (2018) https://doi.org/10.1038/s41584-018-0065-x Published online 14 August 2018
In the section ‘Combining B cell-targeted therapies’ in the originally published version of this article, the 24-week interim analysis for the CALIBRATE study was incorrectly given as the 2- to 4-week interim analysis. This error has now been corrected in the HTML and PDF versions of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McClure, M., Gopaluni, S., Jayne, D. et al. Publisher Correction: B cell therapy in ANCA-associated vasculitis: current and emerging treatment options. Nat Rev Rheumatol 14, 741 (2018). https://doi.org/10.1038/s41584-018-0116-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-018-0116-3
